+958.0%
MRNA vs FDX
+111.3%
+846.7%
-95.4%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for all.
| Period | Portfolio | FDX | Excess | Alpha |
|---|---|---|---|---|
| 1D | -4.8% | -0.5% | -4.3% | -4.7% |
| 7D | -20.9% | -1.3% | -19.5% | -20.6% |
| 30D | -13.3% | +8.3% | -21.6% | -14.7% |
| 3M | +212.6% | -2.7% | +215.2% | +214.3% |
| 6M | +309.0% | +7.7% | +301.4% | +300.3% |
| YTD | +567.3% | +38.4% | +528.9% | +515.6% |
| 1Y | +689.7% | +52.7% | +637.0% | +613.1% |
| 3Y | +157.4% | +63.9% | +93.5% | +126.3% |
| 5Y | -21.7% | +78.4% | -100.1% | -33.9% |
| All | +958.0% | +111.3% | +846.7% | +930.9% |
Cumulative growth
Daily Returns
Daily percentage return beside FDX.
Daily Out/Under-Performance
Portfolio return minus FDX return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × FDX return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over all: compounded portfolio wealth divided by compounded FDX wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
all analysis · Full analysis span regression · 6 months rolling